|
Volumn 6, Issue 3, 2000, Pages 121-126
|
Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibody
a a a a a a a |
Author keywords
Adhesion molecules; Human clinical studies; Immune suppression; Lymphocytes; Neutrophils
|
Indexed keywords
CD11 ANTIGEN;
CD18 ANTIGEN;
HUMAN MONOCLONAL ANTIBODY;
HUMAN MONOCLONAL ANTIBODY HU23F2G;
MONOCLONAL ANTIBODY CD11 ANTIGEN;
MONOCLONAL ANTIBODY CD18 ANTIGEN;
ROVELIZUMAB;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CELL MIGRATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELAYED HYPERSENSITIVITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
IMMUNOSUPPRESSIVE TREATMENT;
LEUKOCYTE ADHERENCE;
LEUKOCYTE ADHESION DEFICIENCY;
MALE;
NEUTROPHIL;
NORMAL HUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN INFLAMMATION;
|
EID: 0034490063
PISSN: 13684736
EISSN: None
Source Type: Journal
DOI: 10.1080/mccm.6.3.121.126 Document Type: Article |
Times cited : (7)
|
References (37)
|